Association Between PSCA Variants and Duodenal Ulcer Risk by Usui, Yoshiaki et al.
Original Article J Epidemiol 2021;31(1):12-20
Impact of PSCA Polymorphisms on the Risk of Duodenal Ulcer
Yoshiaki Usui1,2, Keitaro Matsuo3,4, Isao Oze3, Tomotaka Ugai3, Yuriko Koyanagi1, Yoshinobu Maeda2,
Hidemi Ito1,5, Asahi Hishida6, Kenji Takeuchi6, Takashi Tamura6, Mineko Tsukamoto6, Yuka Kadomatsu6,
Megumi Hara7, Yuichiro Nishida7, Ippei Shimoshikiryo8, Toshiro Takezaki8, Etsuko Ozaki9, Daisuke Matsui9,
Isao Watanabe9, Sadao Suzuki10, Miki Watanabe10, Hiroko Nakagawa-Senda10, Haruo Mikami11,
Yohko Nakamura11, Kokichi Arisawa12, Hirokazu Uemura12, Kiyonori Kuriki13, Naoyuki Takashima14,
Aya Kadota15, Hiroaki Ikezaki16, Masayuki Murata16, Masahiro Nakatochi17, Yukihide Momozawa18,
Michiaki Kubo18, and Kenji Wakai6
1Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center, Nagoya, Japan
2Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceuticals Sciences, Okayama, Japan
3Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center, Nagoya, Japan
4Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
5Division of Descriptive Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
6Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan
7Department of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan
8Department of International Island and Community Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
9Department of Epidemiology for Community Health and Medicine Kyoto Prefectural University of Medicine, Kyoto, Japan
10Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
11Cancer Prevention Center, Chiba Cancer Center Research Institute, Chiba, Japan
12Department of Preventive Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
13Laboratory of Public Health, University of Shizuoka, Shizuoka, Japan
14Department of Public Health, Faculty of Medicine, Kindai University, Osaka, Japan
15Department of Public Health, Shiga University of Medical Science, Otsu, Japan
16Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan
17Department of Nursing, Nagoya University Graduate School of Medicine, Nagoya, Japan
18Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
Received August 2, 2019; accepted November 22, 2019; released online December 14, 2019
ABSTRACT
Background: While duodenal ulcer (DU) and gastric cancer (GC) are bothH. pylori infection-related diseases, individuals with DU
are known to have lower risk for GC.Many epidemiological studies have identified the PSCA rs2294008 T-allele as a risk factor of
GC, while others have found an association between the rs2294008 C-allele and risk of DU and gastric ulcer (GU). Following these
initial reports, however, few studies have since validated these associations. Here, we aimed to validate the association between
variations in PSCA and the risk of DU=GU and evaluate its interaction with environmental factors in a Japanese population.
Methods: Six PSCA SNPs were genotyped in 584 DU cases, 925 GU cases, and 8,105 controls from the Japan Multi-Institutional
Collaborative Cohort (J-MICC). Unconditional logistic regression models were applied to estimate odds ratios (ORs) and 95%
confidence intervals (CIs) for the association between the SNPs and risk of DU=GU.
Results: PSCA rs2294008 C-allele was associated with per allele OR of 1.34 (95% CI, 1.18–1.51; P = 2.28 × 10−6) for the risk
of DU. This association was independent of age, sex, study site, smoking habit, drinking habit, and H. pylori status. On the other
hand, we did not observe an association between the risk of GU and PSCA SNPs.
Conclusions: Our study confirms an association between the PSCA rs2294008 C-allele and the risk of DU in a Japanese
population.
Key words: PSCA; duodenal ulcer; cross-sectional study; Japan
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INTRODUCTION
Peptic ulcer—duodenal ulcer (DU) and gastric ulcer (GU)—is
one of the most common gastrointestinal diseases, with an
estimated lifetime prevalence of 5–10% in the general
population.1 Peptic ulcer is defined as a mucosal defect which
penetrates through the muscularis mucosa with a diameter of at
least 0.5 cm.2 Among the various risk factors of peptic ulcer
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reported to date, including smoking and drinking, one of the main
factors is infection with Helicobacter pylori (H. pylori),3,4 which
is an established risk factor of gastric cancer.5
While both DU and gastric cancer (GC) are H. pylori infection-
related diseases, individuals with DU are well known to have a
lower risk for GC.6,7 It is increasingly clear that these hetero-
geneities are influenced by not only bacterial but also host factors.
A genome-wide association study (GWAS) found an association
between PSCA rs2294008 T-allele and the risk of GC (per allele
OR 1.67, P value 2.2 × 10−15) in a Japanese population,8 while a
second GWAS found associations between variations in PSCA
gene and ABO gene and the risk of DU in an Japanese popula-
tion.9 These latter authors reported that the PSCA rs2294008
C-allele increased the risk of DU (per allele OR 1.84, P value
3.92 × 10−33) but decreased that of GC (per allele OR 0.79, P
value 6.79 × 10−12).9 In addition, they reported that the PSCA
rs2294008 C-allele increased the risk of GU (per allele OR 1.13,
P value 5.85 × 10−7); however, ABO polymorphisms are not
significantly associated with the risk of GU.10 They also reported
the function relevance of PSCA for peptic ulcer and gastric
cancer8,9; on the other hand, the function relevance of ABO for
peptic ulcer has not been clarified yet. The association between
DU=GC and these risk factors is summarized in Figure 1.
Following these initial reports, however, few studies have since
validated this association.
Here, we conducted a cross-sectional study to replicate the
association between the variations in the previously reported
PSCA loci9,10 and risk of DU=GU, and evaluate the interaction
between these variations and smoking=drinking status and
H. pylori status on the risk of DU=GU in a Japanese population.




The Japan Multi-Institutional Collaborative Cohort (J-MICC)
study is a large cohort study launched in 2005 to confirm and
detect gene-environment interactions in lifestyle-related disease.
Details of the J-MICC study have been reported elsewhere.11
Briefly, the study includes 92,647 participants aged 35–69 years
from 13 areas throughout Japan (Aichi, Chiba, Fukuoka, Iga,
Kagoshima, Kyushu-KOPS, Kyoto, Okazaki, Sakuragaoka, Saga,
Shizuoka-Daiko, Takashima and Tokushima sub-cohorts) as at
end of March 2014. All participants gave written informed
consent to participate; answered a questionnaire that inquired
about lifestyle-related factors, past medical history, medication
status and anthropometric characteristics; and provided a blood
sample. The study protocol was approved by the Ethics
Committees of Nagoya University Graduate School of Medicine
and the other institutions participating in the J-MICC study. The
present study was conducted in accordance with the principles
expressed in the World Medical Association Declaration of
Helsinki. A total of 14,539 participants were randomly selected to
be genotyped from 47,163 participants in 12 areas (except for the
Iga sub-cohort, where the survey was conducted from 2013 to
2014) recruited between 2004 and 2013. Subjects were selected
as shown in Figure 2. We excluded 26 subjects because of
inconsistent baseline information between the questionnaire and
genotyping on sex; 422 whose genotype data did not meet quality
control (QC) filters; 32 because of a lack of questionnaire data;
2,743 with a history of cancer; and 1,239 with a lack of data
on ulcer status. In addition, to clarify the substantial impact on
the risk of DU or the risk of GU, we excluded 463 with DU=GU
overlap cases. Finally, we selected 9,614 subjects for
participation in this study.
Past medical history and lifestyle-related factors
The questionnaire for the J-MICC study included questions on
past medical history, and cigarette smoking, alcohol drinking, and
coffee drinking habits. Medical histories for DU and GU were
enquired about in the three categories of never, past, and current.
The combination of a past and current medical history of DU=GU
was considered positive, and otherwise as negative. Smoking=
drinking habits were enquired about in the three categories of
never, former, and current. Former smokers=drinkers were
defined as those who had quit smoking=drinking for more than
1 year. Never smokers were defined as those who smoked less
than 100 cigarettes in their lifetime. We defined the combination
of former and current smokers=drinkers as ever smokers=
drinkers. Smoking habit was evaluated in pack-years, calculated
by multiplying the number of packs consumed per day by the
number of years of smoking. Alcohol consumption of each











Figure 1. Association between duodenal ulcer/gastric cancer and host factors (PSCA rs2294008). H. pylori infection increased
the risk of both gastric cancer and duodenal ulcer. On the other hand, PSCA rs2294008 C-allele decreased the risk of
gastric cancer and increased that of duodenal ulcer.
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was estimated as the average number of drinks per day, which
was converted into a Japanese sake equivalent. One “go” of
Japanese sake contains 23 g of ethanol, which is equal to one
large bottle (633mL) of beer, 108mL of shochu (distilled spirit),
two shots (57mL) of whiskey, or two and a half glasses of wine
(200mL). Total alcohol consumption was determined as the
total sum of pure ethanol consumption (g=day) of each alcohol
beverage. Coffee consumption was obtained in terms of the
frequency and amount of cups according to the following
categories: almost none, 1–2 cups=week, 3–4 cups=week, 5–6
cups=week, 1–2 cups=day, 3–4 cups=day, and ≥5 cups=day. We
classified coffee consumption based on its distribution among
the subjects as almost none, <1 cup of day, and ≥1 cup of day.
This study is based on the data version J-MICC_CS_20180111.
Genotyping and quality control filtering
DNA was prepared from buffy coat fractions using a BioRobot
M48 Workstation (Qiagen Group, Tokyo, Japan) at the central
study office. For the samples from two areas (Fukuoka and
Kyushu-KOPS), DNA was extracted from samples of whole
blood using an automatic nucleic acid isolation system (NA-
3000; Kurabo, Osaka, Japan). Genotyping for all 14,539 study
participants from the 12 areas of the J-MICC Study was done at
the RIKEN Center for Integrative Sciences using a Human-
OmniExpressExome-8 v1.2 Bead Chip array (Illumina Inc., San
Diego, CA, USA). The 26 samples with inconsistent sex
information between the questionnaire and genotyping results
were excluded. The identity-by-descent method implemented in
the PLINK 1.9 software12 found 388 close relationship pairs
(pi-hat > 0.1875) and one sample of each pair were excluded.
Principal component analysis13,14 with the 1,000 Genomes
reference panel (phase 3)15 detected 34 subjects whose estimated
ancestries were non-Japanese,16 and these were also excluded.
The remaining 14,091 samples all met the sample-wise genotype
call rate criterion (≥0.99). Single nucleotide polymorphisms
(SNPs) with a genotype call rate <0.98, a Hardy-Weinberg
equilibrium exact test P value <1 × 10−6, a minor allele
frequency of <0.01, or a departure from the allele frequency
computed from the 1,000 Genomes Project phase 3 EAS samples
were removed. Non-autosomal SNPs were also removed. This
QC filtering resulted in 14,091 samples and 570,162 autosomal
variants.
Genotype imputation
Genotype imputation was performed using SHAPEIT17 and
Minimac318 software base on the 1,000 Genomes reference panel
(phase 3). After genotype imputation, variants with an imputation
quality r2 < 0.3 were excluded, resulting in 12,617,547 variants.
In our primary analysis, we used imputed genotype data, namely
GT format output by Minimac3, estimation of most likely
genotype. We also evaluated allele dosage data by imputation as
well to evaluate consistency with genotype data analysis.
Candidate SNP selection
To reduce the number of SNPs tested in this analysis, we
prespecified tagSNPs based on HapMap-JPT data using National
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Figure 2. Study subject selection. A total of 14,539 participants were randomly selected for genotyping from 47,163 participants.
We excluded 26 subjects because of inconsistent baseline information between the questionnaire and genotyping on
sex; 422 whose genotype data did not meet quality control (QC) filters; 32 because of a lack of questionnaire data;
2,743 with a history of cancer; 1,239 with a lack of data on ulcer status; and 463 with DU/GU overlap cases. Finally, we
selected 9,614 subjects for participation in this study. QC, quality control; DU, duodenal ulcer; GU, gastric ulcer
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Institute of Health (NIH) LD TAG SNP Selection.19 We selected
PSCA six SNPs and ABO 18 SNPs from eFigure 1 and eFigure 2.
We applied an R2 threshold of 0.8 for SNPs with a MAF of more
than 0.05. We forced the inclusion of previously reported SNPs
(PSCA rs2294008 and ABO rs505922) due their association
with the risk of DU in a previous study.9 In addition, we assessed
accordance with Hardy-Weinberg equilibrium using the chi-
squared test.
Serum sample measurement
We also evaluated H. pylori status by measuring anti-H. pylori
IgG serum antibody in 2,760 samples from four among twelve
study sites of the J-MICC Study (Daiko, Kyoto, Aichi Cancer
Center, and Okazaki). Serum samples were immediately stored at
−80°C until measurement. Anti-H. pylori IgG serum antibody
was measured using a direct ELISA kit, “E plate ‘Eiken’ H. pylori
Antibody” (Eiken Kagaku, Tokyo, Japan), with values of
10.0 units=mL or higher regarded as seropositive according to
the manufacturer’s instructions.
Statistical analysis
First, to narrow down the number of SNPs for interaction
analysis, we analyzed the association of the SNPs with the risk
of DU=GU by unconditional logistic regression analysis adjusted
for age (continuous), sex, and study site. We also analyzed the
association of the SNPs with the risk of H. pylori infection by
the same model. We applied Bonferroni corrected P values
of 0.05=24 to avoid false positive associations. Second, we
examined for interaction between selected SNP and smoking=
drinking status for the risk of DU=GU. We included interaction
term between minor allele numbers (0, 1, and 2) of corresponding
SNP and status (ever vs never) in the models. We added pack-
years for ever smokers and total sum of pure alcohol consumption
(g=day) for ever drinkers as covariates in the models. Finally,
we examined interaction between selected SNP and H. pylori
status for the risk of DU=GU among available data. We included
interaction term between the minor allele numbers (0, 1, and 2) of
corresponding SNP and H. pylori status. Throughout the analysis,
we estimated per allele odds ratios (ORs) and their 95%
confidence intervals (CIs) using the major allele homozygote as
reference. All analyses were performed using STATA version
15.1 software (Stata Corp., College Station, TX, USA).
RESULTS
Our analysis included 584 DU cases, 925 GU cases, and 8,105
controls. Table 1 summarizes the demographic, lifestyle, and
medical characteristics of the study subjects by DU=GU status.
Mean age was 56.2 years in DU, 56.6 years in GU, and 53.1 years
in the controls, respectively. The proportion of males was higher
in the case groups than in the control group (63.4% in DU, 57.6%
in GU, and 41.5% in the controls). The proportion of never
drinkers was lower in the case groups than in the control group
(30.3% in DU, 36.5% in GU, and 42.1% in the controls).
Similarly, the proportion of never smokers was lower in the case
groups than in the control group (40.4% in DU, 44.5% in GU,
and 62.8% in the controls). Although H. pylori status data was
only available for some participants, the proportion who were
H. pylori status-positive was higher in the case groups than in the
control group (12.0% in DU, 13.3% in GU, and 9.6% in the
controls).
eTable 1 shows allele frequencies of PSCA and ABO SNPs at
the survey; the r2 at the imputation; and MAF in the HapMap-JPT
data set, Human Genetic Variation Database (HGVD)20 and








<40 19 (3.25) 26 (2.81) 847 (10.45)
40–49 130 (22.26) 175 (18.92) 2,174 (26.82)
50–59 198 (33.90) 321 (34.70) 2,619 (32.31)
60–69 237 (40.58) 403 (43.57) 2,465 (30.41)
Mean (SD) 56.16 (8.66) 56.60 (8.31) 53.08 (9.62)
BMI, kg=m2 (%)
<21 145 (24.83) 255 (27.57) 2,191 (27.03)
≥21, <23 141 (24.14) 284 (30.70) 2,129 (26.27)
≥23, <25 144 (24.66) 185 (20.00) 1,823 (22.49)
≥25 152 (26.03) 192 (20.76) 1,885 (23.26)
Unknown 2 (0.34) 9 (0.97) 77 (0.95)
Mean (SD) 23.30 (3.19) 22.81 (3.10) 23.03 (3.28)
Sex (%)
Male 370 (63.36) 533 (57.62) 3,365 (41.52)
Female 214 (36.64) 392 (42.38) 4,740 (58.48)
Drinking status (%)
Never 177 (30.31) 338 (36.54) 3,415 (42.13)
Former drinker 16 (2.74) 20 (2.16) 144 (1.41)
Current drinker 390 (66.78) 567 (61.30) 4,574 (56.43)
Unknown 1 (0.17) 0 (0.00) 2 (0.02)
Amount of drinking (%)
0 202 (34.59) 371 (40.11) 3,634 (44.84)
<23g=day 189 (32.36) 272 (29.41) 2,686 (33.14)
≥23, <46 g=day 87 (14.90) 119 (12.86) 761 (9.39)
≥46 g=day 77 (13.18) 119 (12.86) 705 (8.70)
Unknown 29 (4.97) 44 (4.76) 319 (3.94)
Mean (SD) 17.96 (25.79) 17.20 (27.21) 12.89 (23.83)
Smoking status (%)
Never 236 (40.41) 412 (44.54) 5,089 (62.79)
Former smoker 168 (28.77) 237 (25.62) 1,455 (17.95)
Current smoker 180 (30.82) 276 (29.84) 1,557 (19.21)
Unknown 0 (0.00) 0 (0.00) 4 (0.05)
Pack-years (%)
0 237 (40.58) 412 (44.54) 5,105 (62.99)
>0, <20 110 (18.84) 149 (16.11) 1,271 (15.68)
≥20 233 (39.90) 358 (38.70) 1,676 (20.68)
Unknown 4 (0.68) 6 (0.65) 53 (0.65)
Mean (SD) 18.47 (23.22) 18.90 (24.92) 9.95 (18.47)
Coffee consumption (%)
almost none 114 (19.52) 165 (17.84) 1,310 (16.16)
>0, 1> cup of day 158 (27.05) 269 (29.08) 2,224 (27.44)
≥1 cup of day 309 (52.91) 491 (53.08) 4,550 (56.14)
Unknown 0 (0.00) 0 (0.00) 21 (0.26)
H. pylori statusa (%)
Negative 80 (13.70) 174 (18.81) 1,533 (18.91)
Positive 70 (11.99) 123 (13.30) 780 (9.62)
Data unavailable 434 (74.32) 628 (67.89) 5,792 (71.46)
aH. pylori status was evaluated by measuring anti-H. pylori IgG antibody for
2,760 available samples.
Negative: IgG <10.0 unit=mL, Positive: IgG ≥10.0 unit=mL.
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Integrative Japanese Genome Variation Database (IJGVD).21 All
SNPs were in accordance with the Hardy-Weinberg equilibrium.
Imputation quality for all SNPs showed high accuracy (r2 > 0.8).
All SNPs showed a difference in MAF of less than 0.1 between
this survey and the HapMap JPT dataset, HGVD or IJGVD.21
The association of PSCA and ABO SNPs with the risk of DU
and GU is shown in Table 2. The PSCA polymorphisms were
significantly associated with the risk of DU (rs2294008,
rs2920296, and rs2976397), while PSCA polymorphisms were
not associated with the risk of GU. The ABO polymorphisms
were not associated with the risk of DU or GU. We also analyzed
data of allele dosage imputed by Minimac3,18 and consistent
results were observed (as shown in eTable 2). For PSCA
rs2294008, the P value was 2.28 × 10−6 for DU (per allele OR
1.34; 95% CI, 1.18–1.51). Rs2920296 and rs2976397 had also
significant P values, and rs2920296 had the lowest P value, but
we did not choose rs2920296 and rs2976397 for further detailed
analysis based on the fact rs2294008 is the truly functional locus.9
The association of PSCA rs2294008 with the risk of DU=GU
stratified by smoking=drinking status is shown in Table 3.
PSCA rs2294008 was significantly associated with the risk of
DU regardless of smoking status. Similarly, after stratification
by drinking status, PSCA rs2294008 was also significantly
associated with the risk of DU. Regarding GU, we did not
observe any association with PSCA rs2294008 after stratification
by smoking=drinking status. We did not observe obvious
multiplicative interaction between PSCA rs2294008 and smok-
ing=drinking status for the risk of DU=GU. We also examined
interaction between the selected PSCA rs2294008 and coffee
consumption for the risk of DU=GU, but again saw no obvious
multiplicative interaction (data not shown). Addition of pack-
years for ever smokers and g=day for ever drinkers as covariates
resulted in no significant change in point estimates (per allele
OR 1.29; 95% CI, 1.10–1.51 in ever smokers; per allele OR 1.33;
95% CI, 1.15–1.55 in ever drinkers).
We did not observe an association of PSCA and ABO SNPs
and the risk of H. pylori infection (as shown in eTable 3). The
association of PSCA rs2294008 with the risk of DU=GU stratified
by H. pylori status among available data is shown in Table 4.
This analysis included 150 DU cases, 297 GU cases, and 2,313
controls. PSCA rs2294008 was significantly associated with the
risk of DU regardless of H. pylori status. Regarding GU, we did
not observe significant association with PSCA rs2294008 after
stratification by H. pylori status. We did not observe obvious
multiplicative interaction between PSCA rs2294008 and H. pylori
status for the risk of DU=GU.
DISCUSSION
We found a significant association between variations in PSCA
and risk of DU. This association was consistent regardless of age,
sex, and study site. However, we did not find an association
between variations in PSCA and the risk of GU and an association
between variations in ABO and risk of DU=GU. After stratifica-
tion of the environmental factors smoking=drinking and H. pylori
status, PSCA rs2294008 was also significantly associated with
the risk of DU. No obvious multiplicative interaction between
PSCA rs2294008 and smoking=drinking and H. pylori status was
observed.
Our study suggests that PSCA rs2294008 C-allele was
associated with an increased risk of DU in the Japanese
population. This is consistent with previous studies.9,22 The
PSCA gene is located on chromosome 8q24.2 and encodes a cell
membrane glycoprotein which belongs to the Thy-1=Ly-6 family.
Several reports suggest that this glycoprotein is involved in cell
renewal and proliferation.23–25 While overexpressed in some
types of cancers, including prostate, bladder, and pancreatic
cancer,23,26,27 it is downregulated in esophageal and gastric
cancer.28 Functional analysis in a previous GWAS revealed a
considerable function for PSCA rs2294008. Tanikawa et al
reported that PSCA protein encoded by the rs2294008 T-allele
with an additional fragment of nine amino acids at the N-terminus
and its localization changes from the cytoplasm to the cell
surface, whereas short PSCA protein encoded by the rs2294008
C-allele is localized to the cytoplasm. They also suggested that
the shorter PSCA protein encoded by the rs2294008 C-allele
might result in insufficient epithelial proliferation to counteract
the damage due to a lack of functional cell surface PSCA,
resulting in slow recovery from duodenal tissue damage.9 Those
reports may support a significant association between the PSCA
rs2294008 C-allele and risk of DU.
In contrast with DU, we did not observe the association
between PSCA polymorphisms and the risk of GU. Although it is
difficult to completely rule out the possibility of lack of statistical
power, but our result indicates that PSCA polymorphisms have
higher impact on the risk of DU than on the risk of GU. This
difference in the magnitude of association by site is consistent
with the previous reports.9,10 In general, DU and GU have a
different etiological spectrum, and differ with regard to the
severity and distribution of background gastritis.29 DU is usually
diagnosed in patients with high antral inflammatory scores and
high acid secretion, whereas GU is diagnosed in patients with
corporal gastritis or pan-gastritis and with normal or decreased
acid secretion. These differences might be related to the different
impact of these PSCA polymorphisms on the risk of DU and GU.
Further clarification of the biological mechanism is required.
In addition, in contrast with previous reports,9 we did not
observe the association between ABO polymorphisms and the risk
of DU. One of the reason for this discrepancy might be difference
of study population between previous study and this study.
Previous study employed subjects from individuals with 47
diseases at the hospital.9 On the other hand, this study was
population-based cohort study mostly from the general popula-
tion.11 Further evaluation in different population is needed.
This study had several strengths. First, to our knowledge,
it is the largest replication studies of this association in an Asian
population following the initial report. Second, it is the first study
to evaluate the interaction between PSCA rs2294008 and
smoking=drinking and H. pylori status on the risk of DU=GU.
Finally, although it is said that candidate gene approach tends to
have greater statistical power than GWAS,30 we did not observe
previously reported associations.
Several limitations of this study should also be mentioned.
First, it was based on a cross-sectional study in which exposure
and outcome measurements were performed concurrently. This
design generally does not allow proof of causality because the
causal sequence may remain unclear. However, the observed
association between these PSCA polymorphisms and risk of DU=
GU is likely relatively valid, given that genetic polymorphisms
are determined by nature. Second, as the participants in this study
were recruited from selected areas, they may have differed from
the general population. However, the equivalence of genotype
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distributions between our subjects and those in another Japanese
database indicates a lack of such bias. Moreover, our analysis
considered study site in the models, which also reduces the
likelihood of such bias. Third, we assessed H. pylori status for
only some subjects, and the evaluation may be insufficient.
However, many previous studies reported a lack of association
between PSCA rs2294008 and H. pylori infection preva-
lence.9,31–34 and Hishida et al also reported a lack of association
in this population.35 Our result is in accordance with this finding.
Thus, H. pylori infection is less likely to bias the association
between PSCA rs2294008 and DU=GU risk. Fourth, non-
steroidal anti-inflammatory drugs and psychological stress are
also known risk factors of peptic ulcer,1 but we did not consider
these variables in our analysis due to their lack of inclusion in
the questionnaire. Further analysis which considers them would
be informative. Finally, as the information about past medical
history was collected from the questionnaire, it might have been
affected by information bias. However, participants answered the
questionnaire without knowledge of their genotype, making
information bias unlikely; moreover, if any misclassification were
present, it would likely be nondifferential and, therefore, likely to
underestimate the causal association.
In conclusion, this study confirms an association between
the PSCA rs2294008 C-allele and risk of DU in the Japanese
population. This association was independent of age, sex, study
site, smoking habit, drinking habit, coffee consumption, and H.
pylori status. Further studies examining the biological mechanism
behind these associations is required.
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